What is LOPJLB’s current signal on VRAX?

LOPJLB’s latest quantitative signal on Virax Biolabs Group Limited (VRAX) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is VRAX in?

Virax Biolabs Group Limited (VRAX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Virax Biolabs Group Limited (VRAX) do?

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.